Patent details
EP1888548 Title: Quinoline derivative for the treatment of retinal diseases
Basic Information
- Publication number:
- EP1888548
- PCT Application Number:
- PCT/US/2006/020320
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067603886
- PCT Publication Number:
- WO/2006/127945
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Quinoline derivative for the treatment of retinal diseases
- French Title of Invention:
- Dérivé de quinoline pour le traitement de maladies rétiniennes
- German Title of Invention:
- Chinolinderivat zur Behandlung von Netzhauterkrankungen
- SPC Number:
Dates
- Filing date:
- 26/05/2006
- Grant date:
- 22/08/2012
- EP Publication Date:
- 22/08/2012
- PCT Publication Date:
- 30/11/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/02/2008
- EP B1 Publication Date:
- 22/08/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/05/2013
- Expiration date:
- 26/05/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/03/2013
- Name:
- Aldexa Therapeutics Inc.
- Address:
- 15 New England Executive Park, Burlington, MA 01803, United States (US)
Inventor
1
- Name:
- JORDAN Thomas, A.
- Address:
- United States (US)
2
- Name:
- DOWLING John, E.
- Address:
- United States (US)
3
- Name:
- CHABALA John, Clifford
- Address:
- United States (US)
Priority
1
- Priority Number:
- 685460 P
- Priority Date:
- 26/05/2005
- Priority Country:
- United States (US)
2
- Priority Number:
- 723577 P
- Priority Date:
- 04/10/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 277/56;
| Filing date | Document type | Number of pages |
|---|